source
- Synchron pauses second-generation brain-computer interface trial, says pause not safety relatedSynchron, a brain-implant startup, announced it is pausing enrollment in its second-generation brain-computer interface trial. Company officials emphasized the decision is operational and not driv…
- Clene Nanomedicine partners with Veristat to speed data analysis for ALS drug FDA filingClene Nanomedicine has entered a partnership with clinical research organization Veristat. Under the agreement, Veristat will apply its biostatistics platform to speed the generation and analysis…